货号： CL-0575
Price： ￥1800 ￥1800
生长培养基： RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120]
产品信息
| 产品名称 | B-CPAP [BC-PAP; BCPAP]（人甲状腺乳头状癌细胞） |
| 别称 | BC-PAP; BCPAP |
| 生长特性 | 贴壁细胞 |
| 细胞形态 | 圆形/长梭形 |
| 冻存条件 |
冻存液：55% 基础培养基+40% FBS+5% DMSO 温度：液氮 |
| 培养方案A（默认） |
生长培养基:RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120] 培养条件: 气相：空气，95%；CO₂，5%, 温度：37℃ |
| 培养方案B（可选） |
生长培养基: 培养条件: 气相：, 温度：37℃ |
| 推荐传代比例 | 1:3-1:5 |
| 推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
| 背景描述 | Established from the tumor tissue of a 76-year-old woman with metastasizing papillary thyroid carcinoma in 1992. |
| 年龄（性别） | 76Y Female |
| 组织来源 | 甲状腺组织 |
| 细胞类型 | 肿瘤细胞 |
| 肿瘤类型 | 其它肿瘤细胞 |
| 生物安全等级 | BSL-1 |
STR位点信息
STR鉴定图
-
Spatial and Single-Cell Transcriptomics Unraveled Spatial Evolution of Papillary Thyroid Cancer(2024)
作者：Guangzhe Zheng, Shaobo Chen, Wanqi Ma, Quanshu Wang, Li Sun, Changwen Zhang, Ge Chen, Shuping Zhang, Shuguang Chen
期刊：Advanced Science
影响因子：14.3
-
Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission(2024)
作者：Guo Ya-wen, Zhu Lei, Duan Yan-ting, Hu Yi-qun, Li Le-bao, Fan Wei-jiao, Song Fa-huan, Cai Ye-feng, Liu Yun-ye, Zheng Guo-wan, Ge Ming-hua
期刊：Cell Death & Disease
DOI：10.1038/s41419-024-06511-1
影响因子：9.0
引用产品： Nthy-ori 3-1 细胞, TPC-1 细胞, B-CPAP [BC-PAP; BCPAP] 细胞, IHH-4 细胞
-
Contribution of Cancer-Specific Protein Coronas to the Pro-Tumor Effects of Nanoplastics through Enhanced Cellular Interactions(2024)
作者：Yuanqi Tang, Ru Wang, Zhipeng Xu, Jianning Wang, Dongsheng Zhou, Shuping Zhang, Dan Wei, Jiayu Ren, Sijin Liu
期刊：ACS Applied Materials & Interfaces
影响因子：8.3
-
Circ_0004851 regulates the molecular mechanism of miR-296-3p/FGF11 in the influence of high iodine on PTC(2024)
作者：Li Jing-jing, Ru Zi-xuan, Yang Xu, Sun Jing-xue, Wu Yan-mei-zhi, Yang Xiao-yao, Hou Bo-yu, Xue Bing, Ding Chao, Qiao Hong
期刊：Journal of Translational Medicine
DOI：10.1186/s12967-024-05405-2
影响因子：6.1
-
Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis(2024)
作者：Wu Shuhui, Zhu Jingjing, Jiang Tingting, Cui Ting, Zuo Qi, Zheng Guibin, Li Guojun, Zhou Jieyu, Chen Xiang
期刊：Clinical Epigenetics
DOI：10.1186/s13148-023-01622-6
影响因子：5.7
-
Human adipose-derived stem cells promote migration of papillary thyroid cancer cell via leptin pathway(2024)
作者：Bo-Tao Zhang, Ying Li, Qi-Lan Jiang, Rui Jiang, Yang Zeng, Jun Jiang
期刊：ANNALS OF MEDICINE
DOI：10.1080/07853890.2024.2419990
影响因子：4.9
-
AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling(2024)
作者：Gaoda Ju, Tao Xing, Miaomiao Xu, Xin Zhang, Yuqing Sun, Zhuanzhuan Mu, Di Sun, Sen Miao, Li Li, Jun Liang, Yansong Lin
期刊：NEOPLASIA
影响因子：4.8
-
The Prognostic Value and Potential Immune Mechanisms of lncRNAs Related to Immunogenic Cell Death in Papillary Thyroid Carcinoma(2024)
作者：Yixian Wang, Xin Li, Yinde Huang, Qingwei Gang, Mingyu Liu, Han Zhang, Shikai Shen, Yao Qi, Jian Zhang
期刊：Journal of Inflammation Research
影响因子：4.2
-
Role of TNFRSF12A in cell proliferation, apoptosis, and proinflammatory cytokine expression by regulating the MAPK and NF-κB pathways in thyroid cancer cells(2024)
作者：Qiu Xu, Gai Fan, Su Shao
期刊：CYTOKINE
DOI：10.1016/j.cyto.2024.156841
影响因子：3.7
-
A pan-cancer analysis of the prognosis and immune infiltration of eEF1A2 and its potential function in thyroid carcinoma(2024)
作者：Ning Ma, Tian Zhou, Chunyu Li, Xue Luo, Song Chen, Xue-yin Zhu, Xing-hong Chen, Haoxi Liu, Hai-ying Tian, Qing-jun Gao, Dai-wei Zhao
期刊：Heliyon
DOI：10.1016/j.heliyon.2024.e24455
影响因子：3.4
引用产品： TPC-1 细胞, B-CPAP [BC-PAP; BCPAP] 细胞, RPMI-1640 培养基, 特级胎牛血清, DMEM高糖 培养基
-
Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢？
部分细胞是会出现多种培养条件的，我们公司优先选择引种来源的培养条件以及建系者所用培养条件，出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件，为了避免细胞突然更换培养条件后不适应，建议您优先使用厂家推荐的培养条件培养。
识别码示意图
